{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:10:00Z","timestamp":1793322600181,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.intimp.2025.115117","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:55:58Z","timestamp":1751583358000},"page":"115117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["3-hydroxyanthranilic acid analog mitigates ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis through the activation of Nrf2\/HO-1\/GPX4"],"prefix":"10.1016","volume":"162","author":[{"given":"Hao-Yuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Song","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-Huang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.intimp.2025.115117_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"9861","key":"10.1016\/j.intimp.2025.115117_bb0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.intimp.2025.115117_bb0015","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1111\/bph.14951","article-title":"Ageing, sex, and cardioprotection","volume":"177","author":"Ruiz-Meana","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115117_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation","volume":"33","author":"Algoet","year":"2023","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115117_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury","volume":"13","author":"Hausenloy","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115117_bb0030","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","article-title":"Myocardial ischemia\/reperfusion: translational pathophysiology of ischemic heart disease","volume":"5","author":"Heusch","year":"2024","journal-title":"Med"},{"issue":"11","key":"10.1016\/j.intimp.2025.115117_bb0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115117_bb0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2025.115117_bb0045","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.305781","article-title":"MicroRNA-103\/107 regulate programmed necrosis and myocardial ischemia\/reperfusion injury through targeting FADD","volume":"117","author":"Wang","year":"2015","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115117_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.intimp.2025.115117_bb0055","first-page":"935","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations","volume":"38","author":"Hausenloy","year":"2017","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.intimp.2025.115117_bb0060","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115117_bb0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting ferroptosis to Iron out Cancer","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.intimp.2025.115117_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","article-title":"Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney","volume":"19","author":"Bay\u0131r","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115117_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115117_bb0080","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115117_bb0085","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI126428","article-title":"Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation","volume":"129","author":"Li","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.intimp.2025.115117_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217889","article-title":"The molecular mechanisms of Iron metabolism and its role in cardiac dysfunction and Cardioprotection","volume":"21","author":"Ravingerov\u00e1","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115117_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2020.10.307","article-title":"Ubiquitin-specific protease 7 promotes ferroptosis via activation of the p53\/TfR1 pathway in the rat hearts after ischemia\/reperfusion","volume":"162","author":"Tang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"19","key":"10.1016\/j.intimp.2025.115117_bb0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","article-title":"Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis","volume":"147","author":"Cai","year":"2023","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.intimp.2025.115117_bb0105","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1039\/D3FO02633G","article-title":"Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis via the NRF2 signaling pathway","volume":"14","author":"Yan","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2025.115117_bb0110","first-page":"11","article-title":"The role of the kynurenine pathway in cardiovascular disease","author":"Yang","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115117_bb0115","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00018-017-2504-2","article-title":"Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases","volume":"74","author":"Song","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115117_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204006","article-title":"Tryptophan metabolism acts as a new anti-Ferroptotic pathway to mediate tumor growth","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci"},{"issue":"5","key":"10.1016\/j.intimp.2025.115117_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2022.02.007","article-title":"Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling","volume":"82","author":"Fiore","year":"2022","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.intimp.2025.115117_bb0130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41556-024-01360-8","article-title":"A guideline on the molecular ecosystem regulating ferroptosis","volume":"26","author":"Dai","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115117_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-023-00927-1","article-title":"Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT","volume":"30","author":"Ju","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.intimp.2025.115117_bb0140","first-page":"23","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115117_bb0145","article-title":"GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925011075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:19:09Z","timestamp":1786159149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925011075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S1567576925011075"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115117","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-hydroxyanthranilic acid analog mitigates ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis through the activation of Nrf2\/HO-1\/GPX4","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115117"}}